U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
189211189211Adjuvant Palliative Capecitabine and Gemcitabine in Treating Patients With Locally Advanced or Metastatic Biliary Tract CancerCompletedNo Results AvailableExtrahepatic Bile Duct Cancer|Gallbladder Cancer|Liver Cancer|PainDrug: capecitabine plus gemcitabinehttps://ClinicalTrials.gov/show/NCT00073905
189212189212PI-88 in Treating Patients With an Advanced Malignancy (Cancer) or Stage IV MelanomaActive, not recruitingNo Results AvailableMelanoma (Skin)|Unspecified Adult Solid Tumor, Protocol SpecificDrug: PI-88https://ClinicalTrials.gov/show/NCT00073892
189213189213Fludarabine, Cyclophosphamide, and Alemtuzumab in Treating Patients With Recurrent or Metastatic Renal Cell Carcinoma (Kidney Cancer) Undergoing Allogeneic Stem Cell TransplantationCompletedNo Results AvailableKidney CancerBiological: alemtuzumab|Biological: graft-versus-tumor induction therapy|Drug: cyclophosphamide|Drug: fludarabine phosphate|Procedure: allogeneic bone marrow transplantation|Procedure: peripheral blood stem cell transplantationhttps://ClinicalTrials.gov/show/NCT00073879
189214189214Combination Chemotherapy and Celecoxib in Treating Patients With Advanced Non-Small Cell Lung CancerCompletedNo Results AvailableLung CancerDrug: celecoxib|Drug: docetaxel|Drug: irinotecan hydrochloridehttps://ClinicalTrials.gov/show/NCT00073866
189215189215Autologous Incubated Macrophages for Patients With Complete Spinal Cord InjuriesSuspendedNo Results AvailableSpinal Cord InjuryProcedure: Autologous Incubated Macrophages (cell therapy)https://ClinicalTrials.gov/show/NCT00073853
189216189216Study of Levalbuterol, Racemic Albuterol and Placebo in Subjects Twelve Years of Age and Older With AsthmaCompletedNo Results AvailableAsthmaDrug: levalbuterolhttps://ClinicalTrials.gov/show/NCT00073840
189217189217Study of Levalbuterol, Racemic Albuterol and Placebo in Subjects Twelve Years of Age and Older With AsthmaCompletedNo Results AvailableAsthmaDrug: levalbuterol tartrate MDI|Drug: racemic albuterol MDI|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00073827
189218189218Study of Daily Dosing With Levalbuterol, Racemic Albuterol, and Placebo in Pediatric Subjects With AsthmaCompletedNo Results AvailableAsthmaDrug: Levalbuterol tartrate MDI|Drug: racemic albuterol MDI|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00073814
189219189219Pelvic Pain in Women With EndometriosisCompletedNo Results AvailableEndometriosis|Pelvic Pain|Healthy|Tubal Ligationhttps://ClinicalTrials.gov/show/NCT00073801
189220189220Wounded Spirits, Ailing Hearts: Post-Traumatic Stress Disorder and Cardiovascular Disease in IndiansCompletedNo Results AvailableCardiovascular Diseases|Heart DiseasesProcedure: PET Scanshttps://ClinicalTrials.gov/show/NCT00073788
189221189221Epidemiology of Stress and the Metabolic SyndromeCompletedNo Results AvailableCardiovascular Diseases|Heart Diseases|Obesity|Hypertension|Hyperinsulinism|Insulin Resistance|Metabolic Syndrome Xhttps://ClinicalTrials.gov/show/NCT00073775
189222189222Study Evaluating DVS-233 SR In Adult Outpatients With Major Depressive DisorderCompletedNo Results AvailableMajor Depressive DisorderDrug: DVS-233 SRhttps://ClinicalTrials.gov/show/NCT00073762
189223189223Study Evaluating CMC-544 In B-Cell Non-Hodgkin's LymphomaCompletedNo Results AvailableLymphoma, B-CellDrug: Inotuzumab ozogamicin [CMC-544]https://ClinicalTrials.gov/show/NCT00073749
189224189224Safety and Tolerability of I.V. Infusion of MB07133 in Patients With Unresectable Hepatocellular CarcinomaCompletedNo Results AvailableHepatocellular CarcinomaDrug: MB07133 300mg/m2/day|Drug: MB07133 600 mg/m2/day|Drug: MB07133 1200 mg/m2/day|Drug: MB07133 1800 mg/m2/day|Drug: MB07133 2400 mg/m2/dayhttps://ClinicalTrials.gov/show/NCT00073736
189225189225Trial of ABI-007 Administered Weekly in Chemotherapy Naive Patients With Advanced Non-Small Cell Lung CancerCompletedNo Results AvailableNon-Small Cell Lung CancerDrug: ABI-007https://ClinicalTrials.gov/show/NCT00073723
189226189226Study to Evaluate the Effects of Zemplar Injection and Calcijex on Intestinal Absorption of CalciumCompletedNo Results AvailableSecondary Hyperparathyroidism|Chronic Kidney DiseaseDrug: Zemplar|Procedure: 42 Ca carbonate absorption via single tracer method|Drug: Calcijexhttps://ClinicalTrials.gov/show/NCT00073710
189227189227Treatment of Depression in AdultsCompletedNo Results AvailableDepressionDrug: Escitalopram|Behavioral: Interpersonal Psychotherapy|Other: Escitalopram plus IPThttps://ClinicalTrials.gov/show/NCT00073697
189228189228Optimal Treatment Strategies for Sexually Abused ChildrenCompletedNo Results AvailableChild Abuse, SexualBehavioral: Trauma focused cognitive behavioral therapy (TF-CBT)|Behavioral: Brief abuse-focused treatment|Behavioral: Brief coping skills treatment|Behavioral: Extended abuse-focused treatment|Behavioral: Extended coping skills treatmenthttps://ClinicalTrials.gov/show/NCT00073684
189229189229Prevention of Depression in At-Risk AdolescentsCompletedNo Results AvailableDepressionBehavioral: Cognitive-behavioral prevention program|Other: Usual carehttps://ClinicalTrials.gov/show/NCT00073671
189230189230Treating Behavioral Disturbances in Individuals With DementiaCompletedNo Results AvailableDementiaDrug: Citalopram|Drug: Risperidonehttps://ClinicalTrials.gov/show/NCT00073658
189231189231Family and Peer Involvement in the Treatment of Anxiety Disorders in ChildrenCompletedNo Results AvailableAnxiety DisordersBehavioral: Peer/Group CBT|Behavioral: Family/Parents CBThttps://ClinicalTrials.gov/show/NCT00073645
189232189232Acceptance-Based Treatment for Generalized Anxiety DisorderCompletedNo Results AvailableAnxiety Disorders|Generalized Anxiety DisorderBehavioral: Acceptance Based Behavioral Therapyhttps://ClinicalTrials.gov/show/NCT00073632
189233189233Preventing Anxiety Disorders in YouthRecruitingNo Results AvailableAnxiety DisordersBehavioral: Cognitive behavior therapyhttps://ClinicalTrials.gov/show/NCT00073619
189234189234Spinal Cord PlasticityCompletedNo Results AvailableHealthyhttps://ClinicalTrials.gov/show/NCT00073606
189235189235Comparing Angiomax to Heparin With Protamine Reversal in Patients OPCABCompletedNo Results AvailableCardiac Surgery|Coronary Artery Bypass SurgeryDrug: Bivalirudin|Drug: Heparin|Drug: Protaminehttps://ClinicalTrials.gov/show/NCT00073593
189236189236Angiomax in Patients With HIT/HITTS Type II Undergoing Off-Pump Coronary Artery Bypass Grafting (CABG) (CHOOSE)Active, not recruitingNo Results AvailableThrombocytopenia|Thrombosis|Cardiac Disease|Coronary Artery Bypass SurgeryDrug: Angiomax (bivalirudin) anticoagulanthttps://ClinicalTrials.gov/show/NCT00073580
189237189237Alfimeprase for Thrombolysis in Acute Peripheral Arterial OcclusionCompletedNo Results AvailableArterial Occlusive Diseases|Peripheral Vascular Diseases|ThrombosisDrug: Alfimeprasehttps://ClinicalTrials.gov/show/NCT00073554
189238189238A Study of the Safety and Effects of EMD 72000 in Subjects With Recurrent Ovarian CancerCompletedNo Results AvailableOvarian CancerDrug: EMD 72000https://ClinicalTrials.gov/show/NCT00073541
189239189239Study Comparing GW572016 And Letrozole Versus Letrozole In Subjects With Advanced Or Metastatic Breast CancerActive, not recruitingHas ResultsNeoplasms, BreastDrug: Lapatinib (GW572016)|Drug: Letrozolehttps://ClinicalTrials.gov/show/NCT00073528
189240189240Trial of a Novel Fibrinolytic (Alfimeprase) to Clear Thrombosed Vascular Access DevicesCompletedNo Results AvailableCatheters, IndwellingDrug: Alfimeprasehttps://ClinicalTrials.gov/show/NCT00073515

* Görseller ve İçerik tekif hakkına sahip olabilir